That claim is very likely misleading or taken out of context.
The European Medicines Agency (EMA) does not issue blanket statements like “brain damage is possible after a single dose” for all drugs, nor does it order immediate recall of “the drugs” in general terms. When EMA recommends a recall, it is always for a specific medicine or batch, and the reason is clearly defined (e.g., contamination, manufacturing defect, or a particular safety signal).
Also, “brain damage after a single dose” is not a standard regulatory conclusion you’d see stated in that broad way. Serious neurological risks—when they exist—are usually:
- tied to a specific active ingredient
- associated with dose, duration, or pre-existing conditions
- described with precise medical terminology, not general alarm language
What you’re seeing sounds like one of these situations:
- a misinterpreted news headline
- a social media exaggeration
- a claim that removed the specific drug name and context
If you want, paste the full article or tell me the name of the drug being mentioned. I can help you check what the EMA actually said and whether there is a real recall or just misinformation.
